Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS)

被引：0
|
作者：
Erden Atilla
Pinar Ataca Atilla
Sinem Civriz Bozdag
Meltem Kurt Yuksel
Selami Kocak Toprak
Pervin Topcuoglu
Bengu Nisa Akay
Hatice Sanli
Gunhan Gurman
Muhit Ozcan
机构：
[1] Ankara University,BMT Unit, Department of Hematology, Cebeci Hospital, School of Medicine
[2] Ankara University,Department of Dermatology, School of Medicine
来源：
International Journal of Hematology | 2017年 / 106卷
关键词：
Mycosis fungoides; Sezary syndrome; Allogeneic hematopoietic stem cell transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cutaneous T cell lymphoma is a heterogeneous group of lymphoproliferative disorders with different clinical behavior and prognosis in which malignant T cells accumulate in the skin. In the relapsed/refractory stage, treatment strategy varies depending on clinical perspective. We retrospectively evaluated advanced stage relapse or refractory mycosis fungoides and Sezary syndrome patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) at our hospital. The overall response rate was 25%, while the disease progressed and relapsed after transplant in 38% of patients. Allo-HSCT may be a reasonable treatment option in the relapsed/refractory stage.
引用
收藏
页码：426 / 430
页数：4
相关论文
共 50 条
  • [21] Clinical, cytogenetic and molecular remissions after allogeneic hematopoietic stem cell transplantation (HSCT) for refractory Sezary syndrome and tumor-stage mycosis fungoides.
    Molina, A
    Arber, D
    Murata-Collins, JL
    Bernal, A
    Raubitschek, A
    Forman, SJ
    Nademanee, A
    BLOOD, 2001, 98 (11) : 409A - 409A
  • [22] Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD) - the EBMT Lymphoma Working Party Experience
    Duarte, Rafael F.
    Boumendil, Ariane
    Onida, Francesco
    Finel, Herve
    Gabriel, Ian H.
    Arcese, William
    Browne, Paul
    Beelen, Dietrich W.
    Kobbe, Guido
    Veelken, Joan H.
    Arranz, Reyes
    Greinix, Hildegard T.
    Lenhoff, Stig
    Poire, Xavier
    Ribera, Josep
    Thompson, Jacqueline
    Zuckerman, Tzila
    Mufti, Ghulam J.
    Cortelezzi, Agostino
    Olavarria, Eduardo
    Sureda, Anna
    Dreger, Peter
    BLOOD, 2015, 126 (23)
  • [23] Durable Remission of Refractory and Advanced Stage Mycosis Fungoides/Sezary Syndrome (MF/SS) Utilizing an " Outpatient" Alemtuzumab and Fludarabine- Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)
    Phuong Vo
    Srinivasan, Ramaprasad
    Purev, Enkhtsetseg
    McDuffee, Emily
    Cook, Lisa
    Worthy, Tatyana
    Hawks, Geri
    Patricia, Prince
    Shalabi, Reem
    Wells, Brian
    Reger, Robert
    Khuu, Hanh
    Stroncek, David
    Tian, Xin
    Geller, Nancy
    Aue, Georg
    Childs, Richard
    BLOOD, 2017, 130
  • [24] Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS)
    Jothishankar, Balaji
    Venkataraman, Girish
    Goldberg, Reva C.
    Abdulla, Farah
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2019, 43
  • [25] GENOTYPIC ANALYSIS OF PERIPHERAL-BLOOD IN MYCOSIS FUNGOIDES SEZARY SYNDROME (MF SS)
    WOOD, GS
    WEISS, LM
    ABEL, EA
    HOPPE, RT
    SKLAR, J
    CLINICAL RESEARCH, 1988, 36 (01): : A255 - A255
  • [26] Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and Sezary syndrome (SS)
    Shalabi, Doaa
    Bistline, Anna
    Alpdogan, Onder
    Kartan, Saritha
    Mishra, Anjali
    Porcu, Pierluigi
    Nikbakht, Neda
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (01)
  • [27] Allogeneic stem cell transplantation in advanced stage mycosis fungoides and Sezary syndrome: 2018 update of the Milan experience
    Onida, Francesco
    Saporiti, Giorgia
    Violetti, Silvia Alberti
    Tagliaferri, Elena
    Grifoni, Federica
    Binda, Francesca
    Fanoni, Daniele
    Orofino, Nicola
    Sciume, Maria Rita
    Cortelezzi, Agostino
    Berti, Emilio
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : S35 - S36
  • [28] Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sezary syndrome
    Onida, F.
    Saporiti, G.
    Berti, E.
    Della Volpe, A.
    Annaloro, C.
    Usardi, P.
    Tagliaferri, E.
    Vener, C.
    Vezzoli, P.
    Rambaldi, A.
    Bruno, B.
    Deliliers, G. Lambertenghi
    BONE MARROW TRANSPLANTATION, 2007, 39 : S40 - S40
  • [29] Allogeneic Stem-Cell Transplantation for advanced mycosis fungoides/Sezary syndrome: Single-center experience
    Atilla, E.
    Sahin, D.
    Ataca, P.
    Bozdag, S. Civriz
    Toprak, S. K.
    Yuksel, M. Kurt
    Topcuoglu, P.
    Akay, B. N.
    Sanli, H.
    Gurman, G.
    Ozcan, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5618 - 5619
  • [30] Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and sezary syndrome
    Singh, L.
    Hosing, C.
    Duvic, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S91 - S91
12345